Drugs / Lacidipine
Lacidipine
Trials 9 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT02203500 | Oct 1998 → Jan 1999 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02218684 | Sep → Nov 1998 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02232607 | Apr 1998 → Jun 1999 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT02177331 | Jun 1995 → Jan 1998 | hypertensive disorder | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 45 trials | ||||||
| Phase 4 | NCT00533858 | Sep 2007 → Sep 2008 | hypertensive disorder | Seoul National University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT00460915 | Jan 2007 → Jul 2009 | hypertensive disorder | Korea University Guro Hospital | Completed | No outcome recorded |
| Phase 4 | NCT00338338 | Nov 2005 → Sep 2007 | essential hypertension | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 4 | NCT00328965 | Nov 2004 → May 2006 | essential hypertension, type 2 diabetes mellitus | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 4 | NCT02235402 | Dec 1997 → Mar 2000 | hypertensive disorder | Boehringer Ingelheim | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02264158 Comparator | Sep 2001 → Mar 2002 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02209649 Comparator | Oct → Dec 1999 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lacidipine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02177331 ↗ |
| Known as | GR 43659X | ChEMBL registry synonym — accepted as the source's own label CHEMBL460291 ↗ |
| Known as | Lacidipino | ChEMBL registry synonym — accepted as the source's own label CHEMBL460291 ↗ |
| Known as | Molap | ChEMBL registry synonym — accepted as the source's own label CHEMBL460291 ↗ |
| Known as | Motens | ChEMBL registry synonym — accepted as the source's own label CHEMBL460291 ↗ |
| Modality | Small molecule | — CHEMBL460291 ↗ |
| Route | Oral | “Lacidipine 4 or 6 mg (oral)” NCT00338338 ↗ |